BRCA1 and breast carcinoma: The molecular pathway of cisplatin-induced apoptotic cell death for TNBC was revealed using triple-negative BRCA1-deficient breast cancer HCC1937 cells and triple-negative BRCA1 wild-type breast cancer MDA-MB-468 cells [20].